Biography for Damian Garde
Damian Garde, Editor
Damian is an editor with Fierce's life sciences publications, writing for FierceBiotech, FierceMedicalDevices and FierceCRO. Prior to joining Fierce, he worked for Patch.com in Maryland, and The Albuquerque Journal and Weekly Alibi in Albuquerque, NM. Damian lives in Washington, DC, and considers himself the foremost Carmelo Anthony apologist in the greater metropolitan area. You can email him at email@example.com and follow @DamianFierce on Twitter.
Articles by Damian Garde
Austin, TX's Apollo Endosurgery traded $90 million for Allergan's under-performing Lap-Band technology last year, and now the company is rolling out a marketing effort of its own, looking to succeed where its forebear struggled.
Despite shifting reimbursement policies and industrywide pricing pressures, it's a good time to be a medical device sales rep, according to a new survey. The sector's sellers are making more money than their pharma counterparts, MedReps.com reports, and they picked up a 5% raise over last year.
Singapore medical device outfit Biosensors International is shaking up its boardroom after a tepid financial performance, working to move on from what it deemed "a challenging year."
Belgian-Israeli startup Nyxoah picked up €8 million ($10.9 million) in financing to advance its tiny neurostimulation treatment for obstructive sleep apnea.
Aliso Viejo, CA's Cianna Medical has locked down a credit facility worth up to $10 million, cash the company will use to market its device designed to deliver radiation treatment to patients with early-stage breast cancer.
CareFusion's Alaris pump is again the subject of a recall, earning the FDA's most serious designation over a software problem that can muddle scheduled infusions and put patients at risk.
The Ann Arbor, MI, devicemaker has pulled together more than $14 million in equity financing to support its ultrasound-powered ablation technology, a device the company said can treat enlarged prostates without the need for surgery.
AcuFocus, an ophthalmic device outfit backed by Medtronic, is working to get its implant approved in the U.S., and the company is preparing to make its case to FDA advisers.
A patent dispute between dialysis giants Baxter and Fresenius Medical Care won't make its way to the Supreme Court, leaving open an intellectual property issue that has troubled some devicemakers.
Janssen, the biotech unit of Johnson & Johnson, is looking beyond just pharmaceuticals with its latest life sciences incubator, seeking out medical device and diagnostics startups to fill its planned lab space.